Since 2013, healthcare expenditure on laboratory services in France has shown a downward trend, with minimal fluctuations. The expenditure, measured as a unit of GDP, remained stable at 0.22 until 2016, then gradually declined to 0.2 by 2018, followed by minor variations in subsequent years, returning to 0.21 in 2020 and stabilizing through 2023. Year-on-year variation showed significant declines in 2017 and 2018 at -4.55% and -4.76% respectively, with a notable 5% increase in 2020. However, from 2020 to 2023, the value remained steady at 0.21. The compound annual growth rate (CAGR) shifted from negative -0.89% in early years to a positive 0.98% by 2023.
Forecasts until 2028 depict a slight reduction to 0.2, reflecting a forecasted 5-year CAGR of -0.97% and an overall growth rate decrease of -4.76% by 2028. This suggests a stagnation and slight decrement in expenditure percentage relative to GDP.
Future trends to watch for include potential influences from technological advancements in laboratory services, policy changes in healthcare funding, and economic factors affecting the GDP. These could stabilize or counteract the projected decline in expenditure.
